Gyroscope Therapeutics
Sarah Hui is a seasoned financial professional with extensive experience as a Senior Financial Analyst, currently at COMPASS Pathways since August 2023. Previous roles include Senior Financial Analyst at Gyroscope Therapeutics and Finance Analyst at Cancer Research UK, where responsibilities encompassed cost modeling for R&D projects, budgeting, forecasting, and providing management information. Sarah has a solid background in project accounting from BBC Media Action and significant tax consulting experience at PwC. Additionally, a Bachelor’s Degree in Accounting and Finance was earned from the University of Bath.
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).